We are live on ! Find out more
TPCW

TD Private Client Wealth Portfolio holdings

AUM $4.82B
1-Year Est. Return 15.21%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+15.21%
3 Year Est. Return
+48.23%
5 Year Est. Return
+55.79%
10 Year Est. Return
AUM
$4.82B
AUM Growth
+$128M
Cap. Flow
+$215M
Cap. Flow %
4.47%
Top 10 Hldgs %
40.37%
Holding
1,756
New
124
Increased
673
Reduced
606
Closed
107

Sector Composition

Rank Sector Weight
1 Technology 5.99%
2 Financials 3.62%
3 Healthcare 2.76%
4 Industrials 2.63%
5 Communication Services 2.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLVM icon
1351
Sylvamo
SLVM
$1.48B
$1.27K ﹤0.01%
30
VIOO icon
1352
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.14B
$1.26K ﹤0.01%
11
-9
-45% -$1.05K
FNV icon
1353
Franco-Nevada
FNV
$38.6B
$1.24K ﹤0.01%
5
+3
+150% +$742
FTS icon
1354
Fortis
FTS
$29.7B
$1.23K ﹤0.01%
22
+16
+267% +$879
XRN
1355
Chiron Real Estate Inc
XRN
$536M
$1.22K ﹤0.01%
37
+15
+68% +$527
QQQI icon
1356
NEOS Nasdaq 100 High Income ETF
QQQI
$13B
$1.19K ﹤0.01%
24
+5
+26% +$263
BAC.PRL icon
1357
Bank of America Series L
BAC.PRL
$3.93B
$1.19K ﹤0.01%
1
OSK icon
1358
Oshkosh
OSK
$8.85B
$1.18K ﹤0.01%
8
GTY
1359
Getty Realty Corp
GTY
$2.18B
$1.18K ﹤0.01%
37
KYMR icon
1360
Kymera Therapeutics
KYMR
$9.14B
$1.17K ﹤0.01%
14
+2
+17% +$158
UNIT
1361
Uniti Group
UNIT
$2.66B
$1.16K ﹤0.01%
124
-89
-42% -$698
TNDM icon
1362
Tandem Diabetes Care
TNDM
$1.24B
$1.15K ﹤0.01%
60
FIVE icon
1363
Five Below
FIVE
$11.3B
$1.14K ﹤0.01%
5
IMAX icon
1364
IMAX
IMAX
$2.12B
$1.14K ﹤0.01%
+30
New +$1.11K
CPA icon
1365
Copa Holdings
CPA
$5.67B
$1.14K ﹤0.01%
10
PATH icon
1366
UiPath
PATH
$6.3B
$1.13K ﹤0.01%
102
-9
-8% -$115
ARWR icon
1367
Arrowhead Research
ARWR
$10.1B
$1.13K ﹤0.01%
18
ZM icon
1368
Zoom
ZM
$26.7B
$1.13K ﹤0.01%
14
-13
-48% -$1.09K
NTNX icon
1369
Nutanix
NTNX
$14.9B
$1.1K ﹤0.01%
29
+26
+867% +$1.1K
TMDX icon
1370
Transmedics
TMDX
$2.54B
$1.09K ﹤0.01%
11
SITC icon
1371
SITE Centers
SITC
$231M
$1.09K ﹤0.01%
202
+63
+45% +$386
IOVA icon
1372
Iovance Biotherapeutics
IOVA
$2.24B
$1.08K ﹤0.01%
309
-5
-2% -$16
BLBD icon
1373
Blue Bird Corp
BLBD
$2.58B
$1.08K ﹤0.01%
19
-11
-37% -$593
NTLA icon
1374
Intellia Therapeutics
NTLA
$1.53B
$1.08K ﹤0.01%
84
EWBC icon
1375
East-West Bancorp
EWBC
$18.3B
$1.07K ﹤0.01%
10

Similar funds

TD Private Client Wealth's Q1 2026 Portfolio in Review

As of Q1 2026, TD Private Client Wealth held 1,756 positions worth $4.82B, up 2.7% from $4.69B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

TD Private Client Wealth deployed $215M of net new capital in Q1 2026, opening 124 new positions and adding to 673 existing holdings. Its largest new stake was VanEck Uranium + Nuclear Energy ETF: 44,744 shares worth $5.96M.

By sector, the portfolio is most concentrated in Technology at 6% of assets, down from 6.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $14.2M trimmed.

  • TD Private Client Wealth's largest Q1 2026 buy was VanEck Uranium + Nuclear Energy ETF: 44,744 shares worth $5.96M.
  • TD Private Client Wealth added most to iShares Core MSCI EAFE ETF in Q1 2026, an estimated $24.4M increase.
  • TD Private Client Wealth's biggest Q1 2026 reduction was iShares Russell 1000 Value ETF, cutting an estimated $14.2M.
  • TD Private Client Wealth fully exited Invesco Water Resources ETF in Q1 2026, selling an estimated $665K.
  • TD Private Client Wealth's ten largest holdings make up 40% of its $4.82B portfolio in Q1 2026.
  • TD Private Client Wealth opened 124 new positions and closed 107 in Q1 2026.
  • TD Private Client Wealth's portfolio value rose 2.7% quarter-over-quarter to $4.82B.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.